Terms: = Breast cancer AND ZRSR2, URP, 8233, ENSG00000169249, U2AF1RS2, MGC142040, U2AF1L2, U2AF1-RS2, MGC142014
5 results:
1. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.
Kehm RD; Hopper JL; John EM; Phillips KA; MacInnis RJ; Dite GS; Milne RL; Liao Y; Zeinomar N; Knight JA; Southey MC; Vahdat L; Kornhauser N; Cigler T; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; Daly MB; Terry MB
Breast Cancer Res; 2019 Apr; 21(1):52. PubMed ID: 30999962
[TBL] [Abstract] [Full Text] [Related]
2. Transcriptomic Profiling of MDA-MB-231 Cells Exposed to
Mazzio EA; Lewis CA; Soliman KFA
Cancer Genomics Proteomics; 2017; 14(6):409-425. PubMed ID: 29109091
[TBL] [Abstract] [Full Text] [Related]
3. Splicing factor mutations and cancer.
Yoshida K; Ogawa S
Wiley Interdiscip Rev RNA; 2014; 5(4):445-59. PubMed ID: 24523246
[TBL] [Abstract] [Full Text] [Related]
4. Colorimetric quantification of mRNA expression in rare tumour cells amplified by multiple ligation-dependent probe amplification.
Acero Sanchez JL; Henry OY; Mairal T; Laddach N; Nygren A; Hauch S; Fetisch J; O'Sullivan CK
Anal Bioanal Chem; 2010 Jul; 397(6):2325-34. PubMed ID: 20526769
[TBL] [Abstract] [Full Text] [Related]
5. A new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancer.
Hutton J; Brown R; Borowitz M; Abrams K; Rothman M; Shakespeare A
Pharmacoeconomics; 1996; 9 Suppl 2():8-22. PubMed ID: 10163967
[TBL] [Abstract] [Full Text] [Related]
